Triple-negative breast cancer (TNBC) constitutes 12–17% of all BCs and it is characterized by the lack of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression [2, 3]. Here, ESR1 is linked to triple-negative breast carcinoma.